Member Info for gjbrandon

As well as the results of tests working with AI on water contamination from Modern Water equipment and their 30+ years of development, other pieces of equipment that had been overlooked such as the UV Digester ( launched in 2014 https://modernwater.com/assets/downloads/press/2014/press_release_modern_water_uvi_FINAL.pdf) is being incorporated into the breath test and near-source wastewater detection system that automatically decontaminates any pathogen (bacteria/virus/toxins) leaving no hazardous materials to be disposed of and allows for sustainable recycling of all test materials.

Also, the Volatile Organic Compound (VOC) testing that exists already in the MicroTrace OVA7100 units installed around the world that can detect gases (another area for breath testing). This is the unit that is being retrofitted with AI for pathogen detection.

The 2,700+ known contaminants that exist in the environment are serious hazards to health care of most of the global population and the ability to use AI as an identification tool enhances everything that existed in Modern Water monitoring, just not fully exploited for the benefit of health and medical care, yet.

@GarryParry & @AndyNich What is very apparent is that Modern Water has not only under-exploited technology but unexploited technology that has been sitting in the filing cabinets for years. As standalone elements they make no sense to promote as individual pieces of equipment, but by adding them into existing equipment and adding a data aggregation process and using AI for analysis, these additional elements add valuable insight to clients. All without any serious development cost, as it has already been done. It was a treasure trove of technology £20m of actual spend on research and development long before it merged with DeepVerge.

We are still unearthing hidden gemstones

It is not possible to respond to speculation other than refer interested parties to what is already in the public domain which is fairly comprehensive. In this tweet https://twitter.com/gjbrandon/status/1335010559801094148?s=19 and at these two RNS of 23rd October and 16th November.

https://www.londonstockexchange.com/news-article/DVRG/update-on-detection-products/14756316

https://www.londonstockexchange.com/news-article/DVRG/comment-on-detection-of-covid-19-in-uk-sewage/14731092

I would point out that if Labskin are growing sales, it's because they need additional scientific support to fulfill the orders that continue to grow. Company has grown from 5 employees in August 2018 to 47 as of today and as you can see, hiring more in the midst of the worst pandemic in 100 years, not a single employee was put on furlough and that is just on organic growth.

In response to the clickbait under researched opinionated commentator I decided to provide a 2 minute excerpt on the Company finances from the longer version of the DeepVerge Webinar that can be viewed at 2pm Tuesday the 1st December. https://twitter.com/gjbrandon/status/1332991315815112706?s=20

That thread on twitter also provides except from page 93 of the Offer Document published 13th October 2020 and a link to the webinar registration page. Social media is a great medium, once it is balanced, fair and with no agenda. If you prefer to get your research straight from the horses mouth, or take the advice from a rude opinionated, climate change denier, behind the paywall in a cesspit of rhetorical rantings, who never bothered to read what is in the public domain, then register and tune in to the Webinar.

Enjoy the rest of the weekend.

@Burt I believe there is a misunderstanding on the commentary relating to Helium. They generally invest in company under £50m, but their criteria as previously revealed is where their their holding in any one company is between 15% and 20% of the value of their entire fund, and not a £50m trigger.

@HappyDays2U this is precisely why this research was initiated. Labskin business model is to provide a test platform for Healthcare, Life sciences, Clinical research, Pharmaceutical and Cosmetics industries, with 13 years of development data and 30+ scientific research articles, including previous work with Ebola. The earlier research on Ebola was the initial reason the Labskin team realised the value of providing a platform test on the live tissue, but with AI, the data accumulated would allow the creation of a "Virtual" virus test environment to test products in hours, not weeks or months.

@trillsg, yes very few caught that we are in a number of hospitals with the breath test. However, you will find that these are not UK hospitals, but European ones

As to why after hours, a Board meeting, tax advice and multiple advisors have been involved for weeks. It took until late in the afternoon to complete and as you have seen the last few weeks, we have put out RNS late in the afternoon.

Until the MWG acquisition was closed no management and Board level share option program could be put in place.

Theprevious share option program for staff was put in place at a higher price, but this was at a higher value than 50% above the current share price and above management share option price, so this was adjusted to address the difference.

Every Public company has a share option program. This could, and probably should, have been put in place long ago when the last transaction was completed in May 2019 at a much lower price.

Nobody benefits until the share price is above 30p. Every shareholder benefits when it does.

As a life science company, our clients search for innovation in medical and scientific journals and not the Daily Mail click-bait tabloids.

Using wastewater surveillance to control #COVID19. This was published in the Nov/Dec2020 edition of MedNous, a publication of Evernow Publishing Ltd #DVRG #AVCT #MWG https://deepverge.com/wp-content/uploads/2020/11/SARS-CoV-2-and-wastewater-Nov-Dec-2020.pdf The media publication is here, behind a firewall - http://mednous.com

SOLD 93.466%. #DVRG offer for #MWG is officially closed. Remaining shares will be compulsorily swapped as acceptances exceed 90%. #DeepVerge are now an enlarged group with #Labskin and #ModernWater offices and labs in US, UK, Ireland, China and Japan. #watercrisis #watermonitoring #microtox #microtoxbt #waterinnovation #covid19 #india #microtoxpd #china

@mattynix7, We are getting well paid ('make money') for work we do on the virus with client ingredients but we are not in a position to publish anything we do for clients.

@trillsg The work on the virus on skin, inside and outside the oral cavity is ongoing. There is no race to publish results when it is being paid for by clients testing their ingredients.

@Nixynoo That is why the press releases of both Pfizer and Moderna are political, if not downright dangerous. There is a vaccine on the way, yippee, let's go celebrate, stop wearing masks, life is going to get back to normal. It's won't for a very long time. This is one of the most virulent infectious virus spreading by breath, airborne, dangerous diseases that we have had to confront in a lifetime. In fact since HIV/AIDS and the panic that went on around that in the 80's is the closest that comes to mind.

Wastewater and drinking water testing has been going on for over 30 years and will continue to be tested for as long as society is polluting our rivers, lakes, even reservoirs. Lord knows where the millions of plastic antigen contaminated tests will end up, considering nobody has even thought about adding to the 8 million tonnes of plastic waste into the ocean each year. That is not me focusing on ours is better than theirs argument, just that we, as a society, flit between one crisis and another without thinking the whole thing end to end.

Testing won't go away, above, or below ground. It will be done to test whether you have COVID or a bacterial or any of the 7 Alpha-coronaviruses that cause disease in humans, that have been around since HCov-229E from the mid 60's or HCov-NL63 in the Netherlands since 2003, currently worldwide. What about the Beta coronaviruses like HCov-OC43 around since 1967 in the USA, HCov-HKU1, discovered in 2005 in Hong Kong, or the B-Linage of Beta in SARS-Cov 2002, Guangdong, China, MERS-Cov, 2012, Saudi Arabia, South Korea, or the current SARS-CoV- 2019.

It's not over, by a long shot and testing will never be over for over 2,700+ virus, bacteria and toxins in our water systems around the world.

Never ceases to amaze me on the lack of foresight as news from Moderna comes out. Call me a cynic, but last week Pfizer came out to get their upfront payment and $1.3 billion orders in just from interim results, knowing full well that Moderna and others would easily beat their minus 80 C distribution requirements. So, over the weekend Russian vaccine providers put a headline out saying they are 92% on small numbers of patients tested. What happens? The western media dismiss that vaccine (I don't know whether it is good or bad, either by the way)

So what happens today? Moderna, again with only interim numbers of 95 patients, when they need to get to 164, before they can apply to the FDA for a EUA, are presented to the world as 94% successful. WTF is going on in the pharma world?

There is no testing to see if anyone is infectious while vaccinated. There are so many unanswered questions, but the one thing for sure is that regardless, you will have to test before and after and how will you be able to ensure that anyone who has been given the vaccine will stay immune and for how long?

@Shandypants For clarity.

It is unlikely that many retail investors would fully be aware of the requirements of an acquisition of another public company. However, briefly, it is not possible to complete such a transaction if the company does not provide a working capital report to the NOMAD.

To complete this, the Company must engage an external reporting accountant to undertake a working capital report, where sensitivity tests are carried out on forecasts, based on cash in hand and the risk of less than expected sales over the next 12 months. That single sentence could only have been put into the Offer Document and the transaction could only take place, without a placing, after the WCR was undertaken and provided to both the NOMAD of Modern Water and DeepVerge.

Again, I hope that provides some more substance to my comment.

I do read the comments, and as a CEO a lot longer than 20 years, I understand the value of support from all stakeholders. There is no doubt, when my career is built on turning around companies with failed or failing business models, many long term shareholders will be aggrieved at their loss, but I have to look past that and save the Company that has been inherited. That was done with my private businesses and when it comes to public companies, like Integumen and Modern Water, no funds, massive debt, under exploited assets and an incorrect business model. Sadly many, many millions of pounds lost.

That is my starting point. I kept the name Integumen to show it was turned around, and changed it only when that job was done. Turning a company around takes time, and I can't address issues with short term traders when the project can take up to 2 years, and in between highs and lows in the publicly traded shares will see short term winners and losers, but long term the risks are high at the outset and lower when the company not only survives, but thrives.

Just like Integumen, Modern Water was in a bad condition when we took it over, with a business model that was not viable. The Monitoring division was the uncut diamond, just like Labskin was in Integumen, forgotten and ignored. I have clearly laid out the strategy of the enlarged entity, collaborate, cooperate, integrate and then own, control and dominate the market into where you sell your enhanced technology.

Top of Page 93 of the Offer Exemption Document has the following statement:
17. Working Capital: In DeepVerge’s opinion, the working capital available to the Enlarged Group is sufficient for the Enlarged Group’s present requirements (that is for at least 12 months following the date of this Document)

To suggest otherwise is disingenuous and I have called on those who make such statements to read public documents first, before making off the cuff remarks to the contrary.

Lastly, I do not have any issue whatsoever with comments, complaints, suggestions and make it my responsibility to be open with all our shareholders. I will continue to do so, in between Zoom meetings as I have done since I joined Twitter in 2009, long before DeepVerge, Modern Water or any other companies I am involved in. There are some wonderful people in this group of companies and while you may easily insult me, have a little respect for their effort to build a company for the social good, as well as for the benefit of all stakeholders.

@Chrysalis1 you know it is not possible to disclose the details of the final agreement, which is a framework agreement over the next 3 years, but it will include at some point most if not all of the items mentioned in the earlier paragraph. At this point the use of the new PD and BT equipment is not detailed, but open to be included. Remember, Modern Water equipment has been installed in over 60 countries across the globe and this is another project, not the first.